Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ayurvedic Oral Cannabis Preparation in Peri-operative Breast and Oral Cavity Cancer
NCT05969314Phase 1Active, not recruiting
- Sponsor
- Tata Memorial Hospital
- Start
- Jun 2022
- Primary completion
- Dec 2026
- Modality
- Plant-derived medicinal product
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of cannabis in breast cancer and oral cancer, sponsored by Tata Memorial Hospital. Primary endpoint: Safe dose of oral cannabis preparation at 28 days. Started Jun 2022; status: active, not recruiting.
02
Drugs
cannabis
03
Conditions
breast canceroral cancer
Beyond the preview
Go deeper on NCT05969314.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05969314.